Aspects Regarding the Influence of Obesity on the Molecular Characteristics of Breast Tumors

• Published in: Curēus (Palo Alto, CA) CA), 2022-07, Vol.14 (7), p.e26952-e26952
• Main Authors: Pantelimon, Iuliana, Gales, Laurentia Nicoleta, Anghel, Rodica Maricela, Gruia, Maria Iuliana, Nita, Irina, Matei, Catalina Vali, Bodea, Delia, Stancu, Andra Maria, Pirvu, Edvina, Radu, Mihaela Corina, Dumitrescu, Anca Irina, Manolescu, Loredana Sabina Cornelia
• Format: Article
• Language: English
• Subjects: Adipocytes; Algorithms; Angiogenesis; Antibodies; Antigens; Body fat; Body mass index; Breast cancer; Disease; Epidemiology/Public Health; Estrogens; Growth factors; Medical prognosis; Nutrition; Obesity; Oncology; Statistical analysis; Survival analysis; Tumors; Womens health
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.26952

The influence of excess adipose tissue on the evolution and prognosis of breast cancer has been evaluated in numerous papers over the years. The ways in which obesity can influence the development, progression, and prognosis of this neoplasia are complex and requires the design of new studies, both clinical and preclinical. The aim of this study is to highlight a possible correlation between obesity-specific tumor microenvironment markers (adipokine or leptin) and the different histological subtypes and aggressive characteristics of breast tumors. We prospectively monitored the prognostic values of 39 patients diagnosed with breast cancer who received oncologic-specific treatment or are in follow-up regarding some obesity markers.Our analysis included parameters such as age, body mass index, immunohistochemical characteristics, and plasma concentration of leptin. The methodology was designed to reveal a possible correlation between obesity (quantified by measuring body mass index and waist circumference), the plasma level of leptin, and breast tumor immunohistochemical characteristics. The patients diagnosed with aggressive tumors subtypes (HER2-positive and triple-negative) had a significantly higher body mass index than patients diagnosed with luminal type tumors (32 kg/sqm versus 27 kg/sqm), the difference being 5 kg/sqm. In patients with non-luminal type breast tumors (HER2-positive and triple-negative), serum concentration of leptin is 55 pg/ml compared to 48 pg/ml in luminal type, statistically significant, p=0.0168. Leptin plays an important role in the connection of specific microenvironment tumors to breast cancer. An increased serum concentration of this adipokine was found in patients with HER2-positive and triple-negative breast tumors compared with luminal-type breast tumors, which could open new directions in the research of breast cancer prognosis in obese patients.